<--- Back to Details
First PageDocument Content
Technology / Visual arts / Industrial furnaces / Pottery / Thermal oxidizer / Refractory / Air pollution / NOx / Gasoline / Chemistry / Chemical engineering / Kilns
Date: 2003-12-23 12:32:56
Technology
Visual arts
Industrial furnaces
Pottery
Thermal oxidizer
Refractory
Air pollution
NOx
Gasoline
Chemistry
Chemical engineering
Kilns

REFRACTORY PRODUCTS MANUFACTURING NESHAP: OVERVIEW OF COMPLIANCE OPTIONS §[removed]a) Who is subject to the Refractory Products Manufacturing NESHAP? The Refractory Products Manufacturing NESHAP (national emission standa

Add to Reading List

Source URL: www.epa.gov

Download Document from Source Website

File Size: 133,71 KB

Share Document on Facebook

Similar Documents

小児骨髄異形成症候群の病態に関与するゲノム基盤の同定 東京大学医学部附属病院　無菌治療部　講師　加藤　元博 【背　景】 　小児不応性血球減少症（Refractory

小児骨髄異形成症候群の病態に関与するゲノム基盤の同定 東京大学医学部附属病院　無菌治療部　講師　加藤　元博 【背　景】 　小児不応性血球減少症（Refractory

DocID: 1veBA - View Document

Zampell Completes Refractory Installation Z ampell Refractories, Inc. successfully completed the

Zampell Completes Refractory Installation Z ampell Refractories, Inc. successfully completed the

DocID: 1uKSw - View Document

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

DocID: 1uJQ2 - View Document

GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed/Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate Daniel J. DeAngelo*1, Brian A. Jonas2, Jane L. Liesveld3,

GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed/Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate Daniel J. DeAngelo*1, Brian A. Jonas2, Jane L. Liesveld3,

DocID: 1uIxU - View Document

Case Study Newsletter 11_Overactive Bladder_Richter.qxp_Layout:03 PM Page 1 Advancing Health A CASE STUDY from MedStar Washington Hospital Center Treating Refractory Overactive Bladder:

Case Study Newsletter 11_Overactive Bladder_Richter.qxp_Layout:03 PM Page 1 Advancing Health A CASE STUDY from MedStar Washington Hospital Center Treating Refractory Overactive Bladder:

DocID: 1sUu3 - View Document